Services
   
Bioequivalence Studies and Phase I/ IIa Clinical Trials
  Bio Pharma Services Inc. provides a wide range of services under the management of highly trained and knowledgeable team of professionals. All studies are conducted in accordance with Good Clinical Practices, ICH, Federal Regulations and rigorous Standard Operating Procedures.
  We offer
 
  • Experienced research team of physicians, CRAs, nurses and technicians
  • Rapid subject recruitment
  • Access to Healthy volunteers, special populations, patient populations
  • A focus on volunteer and patient safety
  • Regulatory compliance
  • Fast turn-around time
  • Strict adherence to the protocol
  Services Overview
Protocol development and review
 
  • Bioequivalence (BE) studies
  • Bioavailability (BA) studies
  • Clinical Pharmacokinetic (PK) studies
  • Safety and tolerability studies
  • First-in-human studies
  • First-in-patient studies (proof of concept)
  • Drug-Drug interactions studies
  • Bridging studies
  • Ascending dose studies
  • QTc studies
Clinical Execution of the Protocol
 
  • Extensive database of healthy male and female volunteers, post-menopausal females
  • Toronto site: 3 independent mixed-gender 48-bed units (144 beds) capable of short term & long term confinement, plus a 14-bed First-in-Man Phase I/IIA clinic.
  • Karachi site: 3 independent mixed-gender 40-bed units (120 beds) capable of short term & long term confinement
  • Experienced physicians, nurses, phlebotomists and technicians dedicated to subject safety and data integrity
Clinical Data Management
 
  • Document development and design of case report forms
  • Project management and monitoring
Partner with bioanalytical laboratory
 
  • Method development, validation and transfer
  • High throughput analysis of biological specimens
  • Electronic data transfer and interim reporting
Pharmacokinetic/Pharmacodynamic analysis and statistical analysis
 
  • Analysis and interpretation of analytical and statistical data
  • Pharmacokinetic modeling
  • Population pharmacokinetics
  • Analysis of clinical endpoints
Integrated Report Writing and Electronic Submissions
 
  • Compliant with ICH, and requirements of USA, EMA, TPD and other regulatory agencies as required
  • CTD format reports
  • eCTD
  • Post-submission regulatory follow-up
Quality Assurance auditing with independent reporting to Management